Hydromorphone/promethazine - Charleston Laboratories
Alternative Names: CLP-517; Promethazine/hydromorphoneLatest Information Update: 28 Sep 2021
At a glance
- Originator Charleston Laboratories
- Class Antiemetics; Morphine derivatives; Opioid analgesics; Propylamines; Sedating antihistamines; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists; Muscarinic M1 receptor antagonists; Opioid receptor agonists; Serotonin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Nausea and vomiting; Pain
Most Recent Events
- 28 Sep 2021 No recent reports of development identified for phase-I development in Nausea and vomiting(Prevention) in USA (PO, Immediate release)
- 28 Sep 2021 No recent reports of development identified for phase-I development in Pain in USA (PO, Controlled release)
- 07 Aug 2018 Hydromorphone/promethazine - Charleston Laboratories is available for licensing in World as of 07 Aug 2018. https://charlestonlabs.com